FDA Opens New Path for Generative AI Medical Tools to Reach Patients Before Full Approval
The U.S. Food and Drug Administration is experimenting with a radically different approach to regulating generative artificial intelligence in medicine, allowing selected AI-powered medical devices to reach patients before receiving traditional marketing…
